12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·1 day ago, 07:05 AMNEO+4.65%AMIX-22.76%
NeuroPace's Panel Track Supplement Not Approvable in Current Form, FDA SaysMorningStar·1 day ago, 05:42 PMNPCE+1.69%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·1 day ago, 04:06 PMVTAK-2.79%NPCE+1.69%
NeuroPace says FDA deems epilepsy label expansion filing not approvable in current formPUBT·1 day ago, 03:33 PMNPCE+1.69%
Beyond Big Tech: 10 Under-the-Radar US Stocks Making Moves This WeekGlobal Report·Jul 9 at 09:02 PMCELG.RT0.00%RZLV+4.46%
Capital Rotates into Niche Tech and Healthcare RestructuringsGlobal Report·Jul 9 at 05:03 AMCVBF+9.00%FHTX-0.63%
US Market’s Unclassified Tickers Highlight Shifting Global Supply ChainsGlobal Report·Jul 3 at 06:35 AMSOUL.RT+7.41%TROO+5.45%
Tech Niche Leaders Secure Exabyte Deals and $1.2B Buyouts in AI PushGlobal Report·Jul 3 at 04:03 AMNPCE+1.69%NOVT+1.02%
The Quiet Infrastructure Boom: From Lithium Refineries to Legacy TankersGlobal Report·Jul 3 at 03:32 AMABAT+0.24%NIU+2.94%
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting | NPCE Stock NewsStockTitan·May 28 at 11:05 PMNPCE+1.69%
